Vascular access for autologous peripheral blood stem cells collection by large volume leukapheresis: Single center experience
- 8 November 2023
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 39 (1)
Abstract
Introduction: Peripheral blood stem cell (PBSC) harvesting requires reliable and safe vascular access. In our institution, a change of practice was implemented and the central venous catheter (CVC) placement for all autologous PBSC collections was abandoned in favor of a careful evaluation of peripheral venous access (PVA) for each individual patient. The aim of this prospective study was to evaluate the rate of patients with adequate peripheral veins for autologous PBSC collection and compare patient characteristics, collection efficacy, and complication rate between patients with PVA and CVC.Method: Peripheral veins were assessed by the apheresis nurse team in all patients referred between January 2020 and July 2021 to autologous PBSC collection. Only in case of difficult venous access, CVC was inserted. Large volume leukapheresis (LVL) procedures, which processed ≥3 total blood volumes, were performed.Results: In 65 (57%) patients PVA was used, while 49 (43%) patients required placement of short‐term CVC. Peripheral venous access was successfully used significantly more often in males (69.8%) (P = 0.010), and patients with multiple myeloma (71.0%) than in patients with non‐Hodgkin's lymphoma (35.9%) and Hodgkin's lymphoma patients (33.3%) (P < 0.001). There was a significant difference in the type of prior administered chemotherapy; in the patients who received cytostatics free chemotherapy, PVA was used more often (75.0%) (P = 0.007). In terms of the efficacy and safety of LVLs, there were no differences between procedures performed using PVA and CVCs.Conclusion: Peripheral venous access is feasible for autologous PBSC collection in more than a half of patients, in particular in those with multiple myeloma. Changes in the treatment of multiple myeloma, using new proteasome inhibitors‐based and immunomodulatory agents that do not adversely affect peripheral veins, have enabled the use of PVA even at the high blood flow rates required by LVL. Peripheral venous access is not associated with safety issues or with a lesser collection efficiency, and it is cost‐effective as well. Each patient referred to autologous PBSC collection needs to be evaluated individually by the experienced apheresis team for the most appropriate venous access.Keywords
This publication has 34 references indexed in Scilit:
- Vascular access in therapeutic apheresis: Update 2013Journal of Clinical Apheresis, 2013
- Risk factors for adverse events during collection of peripheral blood stem cellsTransfusion and Apheresis Science, 2011
- Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional studyBone Marrow Transplantation, 2008
- World apheresis registry reportTransfusion and Apheresis Science, 2007
- Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL studyAnnals of Oncology, 2006
- PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patientsTransfusion and Apheresis Science, 2005
- Efficacy and safety of femoral vascular access for peripheral blood stem cell (PBSC) collectionBone Marrow Transplantation, 2003
- Comparison of processing four and five times the patients’ blood volume during peripheral blood stem cell collection and analysis of CD34+38– and CD34+49d+ subsets during apheresisJournal of Cancer Research and Clinical Oncology, 2001
- Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra‐apheresisJournal of Clinical Apheresis, 2001
- Vascular access devices used during harvest of peripheral blood stem cells: high complication rate in patients with a long-term dialysis central venous catheterBone Marrow Transplantation, 1999